Impact of an Optimized Communication on the Readmission for Adverse Drug Event

NACompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

July 19, 2021

Study Completion Date

July 19, 2021

Conditions
Adverse Drug Event
Interventions
OTHER

Optimized information transmission

Sending to the community referring physician by the emergency department an discharge report containing the reason for emergency consultations (report currently made as part of the treatment). Within 72 hours (working hours), the Emergency Clinical Pharmacist contacts the referring physician and the patient's community pharmacist to discuss how to manage the ADE. In parallel, a second report, summary of the ADE (ADE-report), is sent to them. The ADE-report, written and validated by the investigators (emergency physician and clinical pharmacist), includes the type of ADE, the suspected drug(s) and other recommendations: therapeutic modification, referral to specialized consultations (geriatrics ...).

Trial Locations (1)

34295

University Hospital of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03725046 - Impact of an Optimized Communication on the Readmission for Adverse Drug Event | Biotech Hunter | Biotech Hunter